Alumis Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Alumis Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-109.6×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 83% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-79.1×Operating cash was negative last year, while some debt falls due within a year.
Lower than 80% of Healthcare companies in United States.
Cash Cushion Ratio
+31%Cash, after subtracting all debt, equals 31% of its market value (net cash).
Higher than 69% of Healthcare companies in United States.
Tangible Assets Ratio
88%Of every $100 the company owns, $88 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 58% of Healthcare companies in United States.
Tangible Net Worth Ratio
83%Of every $100 of net worth, $83 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 65% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Alumis Inc. made a loss over the last year. Alumis Inc. owes $0.19 for every $1 it owns. Alumis Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAlumis Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.95The share price is 1.95 times Alumis Inc.'s book value per share, lower than 60% of Healthcare companies in United States.
Market cap
$883 MThe total market value of all of Alumis Inc.'s shares at today's price (share price × number of shares), larger than 62% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$452 MWhat Alumis Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.49Net worth divided by the number of shares. The share price of $6.82 is 2.0 times this, which is the P/B above.
Return on equity (ROE)
-93.7%Alumis Inc. lost 93.7% of its shareholders' money over the last year, lower than 69% of Healthcare companies in United States.
Owes vs Owns
0.19×Alumis Inc. owes $0.19 for every $1 it owns (low), lower than 74% of Healthcare companies in United States.
Dividend yield
NoneAlumis Inc. does not currently pay a dividend.
Profit growth
LossAlumis Inc. made a loss in each of the last two years.
Profit margin
-1011.7%Alumis Inc. lost $1012 for every $100 of revenue.
Cash vs debt
Net cashAlumis Inc. held $272 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Alumis Inc.: $883 M ÷ $452 M (30 Jun 2026) = 2.0.
What is Alumis Inc.'s return on equity?
Alumis Inc. lost 93.7% of its shareholders' money over the last year, lower than 69% of Healthcare companies in United States.
How much does Alumis Inc. owe compared with what it owns?
Alumis Inc. owes $0.19 for every $1 it owns (low), lower than 74% of Healthcare companies in United States.
Does Alumis Inc. pay a dividend?
No. Alumis Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.